General
A section of Current Oncology (ISSN 1718-7729).
Section Information
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Immune Checkpoint Inhibitors for Urologic Cancers (Deadline: 1 May 2024)
- An Update on Surgical Treatment for Hepato-Pancreato-Biliary Cancers (Deadline: 15 May 2024)
- Advancements in Clinical Trials in Oncology: Design, Enrichment, Safety, Operations, Patient Centricity, and Endpoints (Deadline: 1 June 2024)
- Physical Activity and Exercise in Cancer Care (Deadline: 10 June 2024)
- Recent Advances in Diagnosis, Treatment and Prognosis of Giant Cell Tumor of the Bone (Deadline: 30 June 2024)
- New Perspectives in Real-World Drug Safety and Effectiveness in Cancer Treatment (Deadline: 15 July 2024)
- Recent Advancements in Malignant Pleural Mesothelioma: Diagnosis, Treatment, and Molecular Mechanisms (Deadline: 15 July 2024)
- Latest Development of Microsatellite Instability in Cancer (Deadline: 31 August 2024)
- The 30th Anniversary of Current Oncology: Perspectives in Clinical Oncology Practice (Deadline: 31 October 2024)
- Integrative and Multi-Modality Therapy in the Next Generation of Hepatocellular Carcinoma Management (Deadline: 31 October 2024)
- New Treatments in Pancreatic Ductal Adenocarcinoma (Deadline: 31 October 2024)
- MRI-Guided Radiotherapy: Hype or Here to Stay? (Deadline: 15 November 2024)
- 2nd Edition: Molecular Testing for Thyroid Nodules and Cancer (Deadline: 14 December 2024)
- Oncoplastic Breast Conserving Surgery: Functional Outcomes and Quality of Life (Deadline: 31 December 2024)
- 2023–2024 Article Series of the Canadian Association of General Practitioners in Oncology (Deadline: 31 December 2024)
- Advances in B-cell Lymphoma: From Diagnostics to Cure (Deadline: 15 June 2025)